ATM and breast carcinoma: To avoid potential selection bias due to long-term deletion of Atm, we generated 4T1 mouse mammary carcinoma cells with doxycycline inducible expression of shRNA targeting either Atm, leading to ATM depletion within 4 days as confirmed by immunoblot analysis, or a non-target control (Supplementary Figure S2).